|  |  | 

India Top Headlines

Covishield comprises more than 90% of the 12.76 crore Covid vaccines administered so far | India News


NEW DELHI: Covishield, from the Oxford / AstraZeneca stable, comprises more than 90 percent of the 12.76 crore Covid-19 vaccines administered nationwide so far, according to government data Wednesday.
Of this, 15 states and territories of the Union have only given Covishield, being manufactured by the Serum Institute of India based in Pune. The other vaccine that is administered in India is the indigenous Covaxin from Bharat Biotech in Hyderabad.
Giving details, of the 127,605,870 Covid-19 vaccination injections administered so far, 11,60,65,107 are from Covishield while 1,15,40,763 are from Covaxin, according to the government’s CO-WIN portal.
Additionally, around 15 Union states and territories, including Goa, Chandigarh, and Jammu and Kashmir, have only administered Covishield to their beneficiaries.
Experts said that Covishield is being produced on a much larger scale than Covaxin due to its greater availability.
Dr Samiran Panda, Head of Epidemiology and Communicable Diseases at the Indian Council of Medical Research, said that Covaxin production will soon increase.
“After which, the vaccine production capacity will increase significantly,” he said.
Bharat Biotech said on Tuesday that the capacity expansion has been implemented at multiple facilities in Hyderabad and Bangalore, to reach approximately 700 million doses per year.
The biotechnology department is also providing financial support such as grants to vaccine manufacturing facilities to improve production capacity.
“The current production capacity of the locally developed Covaxin vaccine will double by May-June 2021 and then will increase almost 6-7 times by July-August 2021, that is, it will increase the production of 10 million doses of vaccine in April 2021 to 60-70 million vaccine doses per month in July-August, “the science and technology ministry said in a statement on Monday.
India granted the emergency use authorization to Covaxin and Covishield, after which the vaccination campaign began in the country on January 16.
Prime Minister Narendra Modi and Foreign Minister S Jaishankar were among those who administered Bharat Biotech’s Covaxin.

Times of India